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Abstract
Background: An increasing number of women are evaluated for potential breast cancer and may experience
mental distress during evaluation. We aim to assess the risks of psychiatric disorders and cardiovascular diseases
during the diagnostic workup of potential breast cancer.
Methods: All women with a new diagnosis of unspecified lump in breast (N = 15,714), benign tumor or breast
cancer in situ (N = 4435), or breast cancer (N = 8512) during 2005–2014 in Skåne, Sweden, were considered as
exposed to a breast diagnostic workup. We used multivariable Poisson regression to compare rates of psychiatric
disorders and cardiovascular diseases during the 6 weeks before the date of diagnosis of these women with the
corresponding rates of women not undergoing such workup. The commonest waiting time for breast cancer
patients was 6 weeks during the study period. A within-individual comparison was performed to control for
potential unmeasured time-stationary confounders.
Results: Compared to the reference, we found a higher rate of psychiatric disorders during the 6 weeks before
diagnosis of benign tumor or breast cancer in situ (incidence rate ratio [IRR], 1.3; 95% confidence interval [CI], 1.1 to
1.5) and breast cancer (IRR, 1.4; 95% CI, 1.2 to 1.6). A higher rate was also noted for cardiovascular diseases (IRR, 1.3;
95% CI, 1.1 to 1.6 for benign tumor or breast cancer in situ, and IRR, 1.9; 95% CI, 1.8 to 2.0 for breast cancer). The
rate increases for breast cancer were greater comparing a diagnostic workup due to symptoms to a workup due to
screening. Little rate increase of neither psychiatric disorders nor cardiovascular diseases was noted during the
6 weeks before the diagnosis of unspecified lump in breast. The within-individual comparison largely confirmed
these findings.
Conclusions: Women with benign and malignant breast tumor had increased rates of psychiatric disorders and
cardiovascular diseases during the waiting for a final diagnosis.
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Background
A growing proportion of the global population is cur-
rently being evaluated for potential cancer, due to
population-based or opportunistic screening. A diagnos-
tic workup of potential cancer—commonly defined as
the period starting from the first suspicion of cancer
until the final diagnosis or primary treatment—may, in-
dependently, have negative health implications. Present
knowledge of such implications is mostly limited to can-
cer over-diagnosis and over-treatment [1]. Although ac-
cumulating evidence suggests that the diagnostic
workup of cancer, regardless of the final result, affects
the general health and well-being of the affected individ-
uals [2–6], little attention has been devoted to assessing
concrete and severe health outcomes in relation to can-
cer diagnostic workup.
Psychiatric disorders and acute cardiovascular events
have been associated with stressful life events [7–13], in-
cluding receiving a cancer diagnosis [14–16]. Our recent
findings demonstrate that cancer patients have highly in-
creased risks of psychiatric disorders and external injur-
ies, not only after cancer diagnosis but also during the
immediate time period before diagnosis [17, 18]. The in-
creased risks before cancer diagnosis might be attribut-
able to the onset of cancer symptoms but could also be
due to the psychological distress experienced during the
clinical evaluation of a potential cancer [17, 18]. To our
best knowledge, no study has however specifically
assessed the risks of psychiatric disorders and cardiovas-
cular diseases during cancer diagnostic workup. Finally,
the population currently being evaluated for potential
cancer is growing, with or without an eventual cancer
diagnosis [19]. It is important therefore to understand
whether this population, especially the ones who are not
eventually diagnosed with cancer, experiences a similar
rise in the risk of these severe outcomes.
To this end, we performed a large population-based
study in Sweden to assess the rates of psychiatric disor-
ders and cardiovascular diseases during the diagnostic
workup of potential breast cancer, due to either findings
from screening or symptoms, with a focus on the waiting
time before receiving a final diagnosis.
Material and methods
Study design
Skåne is a region in southern Sweden with a population
size of ~ 1.3 million [20]. The Skåne Healthcare Register
(SHR) includes all levels of health care provided in
Skåne, including dates of healthcare visits and diagnostic
and procedure codes (surgical or non-surgical). The
coverage of SHR approaches 100% concerning both in-
patient and outpatient specialist care and primary care.
The Swedish Cancer Register has complete information
on all newly diagnosed cancers in Sweden since 1958
[21]. Using the Total Population Register that includes
information on birth, migration, and death of all Swedish
residents, we conducted a cohort study including all
adult women (≥ 18 years) residing during 2005–2014 in
Skåne (N = 608,140). These women were individually
followed from January 1, 2005, to a diagnosis of breast
cancer, a diagnosis of any other cancer, total mastec-
tomy, emigration out of Skåne, death, or December 31,
2014, whichever occurred first, through cross-linkages to
the Cancer Register and the SHR, using the individually
unique personal identification numbers.
Patients with a benign breast tumor undergo a similar
diagnostic workup as breast cancer patients, whereas un-
specified lump in breast is the most common symptom
for symptomatic breast cancer and the main reason for
symptom-based breast diagnostic workup [22]. We
therefore first identified all women that received a diag-
nosis of breast cancer during the study period according
to the Cancer Register (N = 8512). Among women with-
out a breast cancer diagnosis, we then identified women
with benign tumor in breast or breast cancer in situ ac-
cording to the Cancer Register and SHR (N = 4435). As
vast majority of women with benign tumor in breast or
breast cancer in situ have a benign tumor (98.7%), we
refer to this group as patients with benign tumor. Fi-
nally, among women with neither breast cancer nor be-
nign tumor or breast cancer in situ, we identified
women with unspecified lump in breast according to
SHR (N = 15,714). All these women were defined as ex-
posed to a diagnostic workup of potential breast cancer
(Additional file 1: Figure S1). For women with breast
cancer, we used the date of diagnosis as registered in the
Cancer Register (95%) or the SHR (5%), whichever ever
occurred first. For patients with unspecified lump and
benign tumor, we used the date of last corresponding
diagnosis during a workup from the SHR as the date of
diagnosis, if multiple diagnoses were identified. The
International Classification of Diseases (ICD) codes used
for different breast diagnoses are listed in Add-
itional file 1: Table S1.
According to the national cancer care program in
Sweden, the median waiting time from a well-founded
suspicion of breast cancer to the start of initial cancer
treatment is expected to be 28 days, and the waiting time
was 6 weeks for 80% of the breast cancer patients in
Skåne [23]. In the present study, the number of health-
care visits started to increase from the 6th week before
diagnosis, compared to earlier, among women that re-
ceived a diagnosis of breast cancer during the follow-up
(Additional file 1: Figure S2). We estimated therefore the
rates of psychiatric disorders and cardiovascular diseases
during the 6 weeks before the diagnosis of women that
had a breast diagnostic workup. As a contrast, we also
estimated the rates of psychiatric disorders and
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cardiovascular diseases during the time interval from
diagnosis to the day before surgery, among women that
received surgical treatment after diagnosis.
Women that did not have any breast diagnostic
workup during follow-up contributed all their person-
time to the reference group. Women that underwent a
breast diagnostic workup also contributed person-time
to the reference group before the start of such workup.
Ascertainment of psychiatric disorders and cardiovascular
diseases
Psychiatric disorders and cardiovascular diseases diag-
nosed through either primary or specialist inpatient or
outpatient care, according to SHR, were used as the pri-
mary outcomes of interest. We used ICD-10 codes F10-
F99 to identify all diagnoses of psychiatric disorders and
I00-I99 to identify all diagnoses of cardiovascular dis-
eases. Repeated events were taken into account apart
from events that had the same diagnosis and occurred
within 28 days of each other. Because there are deaths
from cardiovascular diseases that are outside the hos-
pital, we also identified deaths due to cardiovascular dis-
eases that were not preceded by a related hospital visit
from the Causes of Death Register and considered them
as additional cardiovascular events. We classified psychi-
atric disorders as stress reaction or adjustment disorder,
depression, anxiety, substance abuse, and others, and
classified cardiovascular diseases as myocardial infarc-
tion, hypertensive diseases or aneurysm of the heart, em-
bolism or thrombosis, stroke, and other diseases of the
circulatory system. Corresponding ICD codes are listed
in Additional file 1: Table S1.
Statistical analysis
We described the characteristics of the exposed women
according to their final diagnosis, including age at diag-
nosis, tumor stage (breast cancer patients alone), surgical
treatment, cohabitation status, preexisting psychiatric
disorders, and preexisting cardiovascular diseases. We
estimated the crude incidence rates (IRs) of psychiatric
disorders and cardiovascular diseases during the 6 weeks
before diagnosis for all exposed women and during the
waiting time for surgical treatment for women that re-
ceived surgery after diagnosis, by dividing the number of
events with the accumulated person-months at risk. We
used Poisson regression to estimate the incidence rate
ratios (IRRs) and their 95% confidence intervals (CIs), by
comparing the IRs of different exposed women with the
IRs of the reference group. Because we took into ac-
count repeated outcomes, we used a clustered sandwich
estimator to account for the intra-individual correlation.
We used attained age as the underlying timescale, and
all analyses were adjusted for cohabitation status and
registered parish (as a proxy for socioeconomic status),
both ascertained from the Total Population Register,
and preexisting psychiatric disorders or cardiovascular
diseases. We ascertained preexisting psychiatric disor-
ders or cardiovascular diseases from the SHR from 2004
onward and updated such information at the beginning
of each time period (i.e., these variables were treated as
time-varying).
To assess potential effect modifications, we performed
stratified analyses by age, calendar period, cohabitation
status, and preexisting psychiatric disorders or cardio-
vascular diseases and used the Wald test to assess the
differences between the stratum-specific estimates. We
separately analyzed psychiatric disorders and cardiovas-
cular diseases that were identified from primary care
alone and from specialist care alone, to examine whether
the results would differ by type of healthcare level used
to ascertain the studied outcomes. To eliminate potential
confounding due to time-stationary factors, we addition-
ally performed a within-individual comparison using
conditional Poisson regression [24]. In this analysis, we
compared the IRs of psychiatric disorders and cardiovas-
cular diseases during the 6 weeks before diagnosis with
the corresponding IRs during the period before these
6 weeks for each woman that had a breast diagnostic
workup. Finally, to assess whether the results would dif-
fer for a breast diagnostic workup due to symptoms
compared to a workup due to screening findings, we
performed a separate analysis during 2009–2014 for
which information on breast cancer screening was
largely available in SHR. Because we used psychiatric
disorders and cardiovascular diseases as two proxies for
severe health outcomes related to stress, in a sensitivity
analysis of the entire study sample, we also estimated
the IRR of having either a psychiatric disorder or a car-
diovascular disease during the 6 weeks before diagnosis
among women with different breast diagnoses.
The assumption of equal-dispersion for Poisson re-
gression was found to hold for all analyses. All analyses
were performed in SAS 9.4 (SAS Institute) and STATA
13.1 (StataCorp LP). The study was approved by the
Central Ethical Review Board in Stockholm, Sweden.
Results
The mean age at diagnosis was 41 years for women with
unspecified lump in breast, 45 years for women with be-
nign tumor, and 63 years for women with breast cancer
(Table 1). Ninety percent of breast cancer patients re-
ceived surgical treatment, whereas 30% of patients with
benign tumor and < 2% of patients with unspecified
lump in breast received surgical treatment. Almost half
of the breast cancer patients diagnosed during 2009–
2014 had a diagnostic workup due to screening (Add-
itional file 1: Table S2).
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Psychiatric disorders
There were 521 women with unspecified lump in breast
(3.3% of all women with lump), 145 women with benign
tumor (3.3% of all women with benign tumor), and 253
women with breast cancer (3.0% of all women with
breast cancer) that were diagnosed with psychiatric dis-
orders during the 6 weeks before diagnosis. Compared
with the reference group, we found an increased rate of
psychiatric disorders during the 6 weeks before diagno-
ses among all exposed women (IR, 25.5 per 1000
person-months; IRR, 1.2; 95% CI, 1.1 to 1.3). The in-
creased rate was mainly noted among women with be-
nign tumor (IRR, 1.3; 95% CI, 1.1 to 1.5) or breast
cancer (IRR, 1.4; 95% CI, 1.2 to 1.6) although only mar-
ginally among women with unspecified lump in breast
(IRR, 1.1; 95% CI, 1.0 to 1.2) (Table 2). Among women
with breast cancer, the rate increase was greater for a
higher stage compared to a lower stage cancer. A statis-
tically significant rate increase was noted for all individ-
ual psychiatric disorders studied before diagnosis of
breast cancer, but only for stress reaction or adjustment
disorder and substance abuse before diagnosis of benign
tumor and for anxiety before diagnosis of unspecified
lump in breast (Table 3).
The rate increase of psychiatric disorders during the
6 weeks before diagnosis was greater among women
diagnosed in early calendar period or women without
preexisting psychiatric disorders, compared to women
diagnosed in late calendar period or women with a his-
tory of psychiatric disorders (P for differences < 0.05)
(Additional file 1: Table S3). Apart from unspecified
lump in breast, the rate increase was noted both for psy-
chiatric disorders ascertained from primary care alone
and for those ascertained from specialist care alone
(Additional file 1: Figure S3). We also noted an in-
creased rate of psychiatric disorders during the waiting
time for surgical treatment among women that received
surgical treatment after diagnosis of breast cancer, but
not after diagnosis of benign tumor or unspecified lump
(Additional file 1: Table S4).
The within-individual comparison confirmed the find-
ings of the main analyses (Table 4). When investigating
the mode of detection (data restricted to 2009–2014),
we found a statistically significantly increased rate of
psychiatric disorders during the 6 weeks before diagnosis
of benign tumor and breast cancer for women that
underwent a diagnostic workup due to symptoms but
not screening (Table 5).
Cardiovascular diseases
There were 284 women with unspecified lump in breast
(1.8% of all women with lump), 110 women with benign
Table 1 Characteristics of women without a breast diagnostic workup and women with a breast diagnostic workup by their final
diagnosis, a population-based cohort study during 2005–2014 in Skåne, Sweden
Characteristics Women without breast diagnostic
workup*






No. of women 579,447 15,714 4435 8512
Age in years at diagnosis, mean
(SD)
– 41 (15) 45 (16) 63 (14)
Tumor stage
T0N0M0/stage 0/ stage I – – – 4456 (52.3%)
Stage II – – – 3109 (36.5%)
Stages III and IV – – – 670 (7.9%)
Missing stage – – – 277 (3.3%)
Surgical treatment
Yes – 288 (1.8%) 1339 (30.2%) 7662 (90.0%)
No – 15,426 (98.2%) 3096 (69.8%) 850 (10.0%)
Cohabitation status
Cohabitating 365,287 (63.0%) 7304 (46.5%) 2105 (47.5%) 4400 (51.7%)
Non-cohabitating 214,160 (37.0%) 8410 (53.5%) 2330 (52.5%) 4112 (48.3%)
Preexisting psychiatric disorders
Yes 43,380 (7.5%) 4426 (28.2%) 1037 (23.4%) 1890 (22.2%)
No 536,067 (92.5%) 11,288 (71.8%) 3398 (76.6%) 6622 (77.8%)
Preexisting cardiovascular diseases
Yes 47,362 (8.2%) 2980 (19.0%) 850 (19.2%) 3189 (37.5%)
No 532,085 (91.8%) 12,734 (81.0%) 3585 (80.8%) 5323 (62.5%)
SD standard deviation
*32 women had mastectomy before the start of follow-up and was not included in further analyses, leaving 579,447 women without any diagnostic workup
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tumor (2.5% of all women with benign tumor), and 708
women with breast cancer (8.3% of all women with
breast cancer) that had a diagnosis of cardiovascular dis-
eases during the 6 weeks before diagnosis. Compared
with the reference group, we found an increased rate of
cardiovascular diseases during the 6 weeks before diag-
noses among all exposed women (IR, 30.0 per 1000
person-months; IRR, 1.5; 95% CI, 1.5 to 1.6). The in-
creased rate was primarily noted among women with be-
nign tumor (IRR, 1.3; 95% CI, 1.1 to 1.6) or breast
cancer (IRR, 1.9; 95% CI, 1.8 to 2.0) but only marginally
among women with unspecified lump in breast (IRR,
1.1; 95% CI, 1.0 to 1.2) (Table 2). The rate increase was
greater for advanced cancer compared to a lower stage
cancer among women with breast cancer. An increased
rate was noted for most of the individual cardiovascular
diseases studied before the diagnosis of breast cancer,
whereas for hypertensive diseases or aneurysm of the
heart before the diagnosis of benign tumor, and for
other diseases of the circulation system before the diag-
nosis of unspecified lump in breast (Table 3).
A statistically significant rate increase of cardiovascular
diseases was noted during the 6 weeks before diagnosis
of breast cancer, regardless of age, calendar period, co-
habitation status, or preexisting cardiovascular disease
(Additional file 1: Table S3). However, among women
with unspecified lump in breast, the IRR was statistically
stronger during 2005–2009, compared to 2010–2014.
Also, among women with benign tumor or breast can-
cer, the IRR was statistically significantly greater when
the women were non-cohabitating, compared to women
that were cohabitating (P for differences < 0.05). The re-
sults did not differ clearly by whether the outcomes were
ascertained through primary care or specialist care alone
(Additional file 1: Figure S3). A rate increase was also
noted during the waiting time for surgical treatment
among women with breast cancer, but not benign tumor
or unspecified lump in breast (Additional file 1: Table
S4).
The within-individual comparison largely confirmed
these findings (Table 4). We found increased rate of car-
diovascular diseases during the 6 weeks before diagnosis
of benign tumor and breast cancer among women that
had a breast diagnostic workup due to screening, and of
breast cancer among women that had a diagnostic
workup due to symptoms, when restricting the analysis
to 2009–2014 (Table 5).
There were 688 women with unspecified lump in
breast (4.4% of all women with lump), 227 women with
benign tumor (5.1% of all women with benign tumor),
and 754 women with breast cancer (8.9% of all women
with breast cancer) that had either a psychiatric disorder
diagnosis or a cardiovascular disease diagnosis during
the 6 weeks before diagnosis. The corresponding IRRs
(95% CIs) were 1.1 (1.1–1.2) for women with unspecified
lump, 1.3 (1.1–1.4) for women with benign tumor, and
1.7 (1.6–1.8) for women with breast cancer during the
6 weeks before diagnosis.
Discussion
This study is the first systematic assessment of clinically
confirmed psychiatric disorders and cardiovascular dis-
eases during a diagnostic workup of potential breast can-
cer, focusing on the time period before diagnosis. We
found that women evaluated for a suspected breast can-
cer had increased rates of psychiatric disorders and car-
diovascular diseases while waiting for their diagnosis.
The rate increases were noted for women diagnosed
with benign as well as malignant breast tumor, but min-
imally among women diagnosed with unspecified lump
in breast. These rate increases appeared stronger for a
diagnostic workup of breast cancer due to symptoms
Table 2 Incidence rates (IRs, per 1000 person-months) and
incidence rate ratios (IRRs) of psychiatric disorders and
cardiovascular diseases during the 6 weeks before diagnosis of
women that underwent a breast diagnostic workup, a
population-based cohort study during 2005–2014 in Skåne,
Sweden
No. of events Crude IR IRR (95% CI)†
Psychiatric disorder
Reference group* 954,351 17.6 1.0
Unspecified lump in breast 578 26.4 1.1 (1.0–1.2)
Benign tumor 155 25.2 1.3 (1.1–1.5)
Breast cancer 278 24.0 1.4 (1.2–1.6)
T0N0M0/stage 0/stage I 149 24.5 1.4 (1.1–1.6)
Stage II 95 22.5 1.4 (1.1–1.7)
Stages III and IV 29 31.8 1.8 (1.2–2.6)
Missing stage 5 13.3 1.0 (0.4–2.5)
Cardiovascular disease
Reference group* 1,094,327 20.1 1.0
Unspecified lump in breast 297 13.6 1.1 (1.0–1.2)
Benign tumor 116 18.9 1.3 (1.1–1.6)
Breast cancer 777 67.2 1.9 (1.8–2.0)
T0N0M0/stage 0/stage I 334 55.0 1.7 (1.5–1.9)
Stage II 284 67.4 1.8 (1.6–2.1)
Stages III and IV 115 126.5 2.8 (2.4–3.3)
Missing stage 44 118.0 2.9 (2.1–3.9)
IR incidence rate, IRR incidence rate ratio
*Reference group included person-time accumulated from women who did
not have any breast diagnostic workup during the follow-up and the person-
time accumulated before the start of workup from women with a breast
diagnostic workup during the follow-up
†CI confidence interval. IRRs were estimated using Poisson regression, by using
attained age as the underlying timescale and adjusting for cohabitation status,
registered parish as a proxy for socioeconomic status, and preexisting
psychiatric disorders (for outcome of psychiatric disorders) or preexisting
cardiovascular diseases (for outcome of cardiovascular diseases)
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compared to a diagnostic workup due to screening find-
ings, as well as among non-cohabitating women and
women without previous history of psychiatric disorders.
Apart from over-diagnosis and over-treatment, other
health impacts of cancer diagnostic workup remain
largely unknown. The limited literature so far has fo-
cused on self-reported psychological symptoms and qual-
ity of life during cancer screening programs [25, 26] and
on patients already diagnosed with cancer [2–6],
whereas data are scarce on concrete and severe health
outcomes during clinical evaluations for potential can-
cer, which could be due to either screening findings or
symptoms. Specifically, little is known about such health
impact among individuals that are evaluated for, but
never diagnosed with, cancer. Diagnostic workup of po-
tential cancer has been suggested to affect general
health, especially the psychosocial spheres of function,
including distress, fear and worry, anxiety, mood
changes, sense of uncertainty, behavioral symptoms,
concerns about future reproduction, and suicide [3–6].
Because almost all studies used self-reported quantitative
measurements [3, 6, 27], the defining and measuring of
immediate and potentially severe health outcomes of
cancer diagnostic workup needs to be improved [25].
The generally low response rate and the highly selected
study participants—mostly healthier than average—in
Table 3 Incidence rates (IRs, per 1000 person-months) and incidence rate ratios (IRRs) of individual psychiatric disorders and
cardiovascular diseases during the 6 weeks before diagnosis of women that had a breast diagnostic workup, a population-based
cohort study during 2005–2014 in Skåne, Sweden


















Stress reaction or adjustment disorder 148,
638
2.7 1.0 102 4.7 1.2 (1.0–1.5) 32 5.2 1.6 (1.1–2.3) 38 3.3 1.5 (1.1–2.0)
Depression 296,
613
5.5 1.0 165 7.5 1.1 (0.9–1.2) 47 7.6 1.2 (0.9–1.7) 91 7.9 1.3 (1.1–1.6)
Anxiety 198,
330
3.6 1.0 147 6.7 1.3 (1.1–1.6) 31 5.0 1.2 (0.8–1.7) 51 4.4 1.3 (1.0–1.7)
Substance abuse 58,007 1.1 1.0 31 1.4 1.1 (0.8–1.6) 16 2.6 2.3 (1.4–3.7) 24 2.1 1.8 (1.2–2.7)
Others 252,
763
4.7 1.0 133 6.1 1.0 (0.8–1.2) 29 4.7 0.9 (0.6–1.3) 74 6.4 1.4 (1.1–1.7)
Cardiovascular disease
Myocardial infarction 18,727 0.3 1.0 3 0.1 0.9 (0.3–2.8) 2 0.3 1.8 (0.4–7.1) 6 0.5 0.8 (0.4–1.9)




9.7 1.0 130 5.9 0.9 (0.8–1.1) 63 10.2 1.5 (1.1–1.9) 419 36.2 2.1 (2.0–2.4)
Embolism or thrombosis 13,511 0.2 1.0 3 0.1 0.8 (0.2–2.4) 1 0.2 0.8 (0.1–5.9) 16 1.4 3.4 (2.1–5.5)
Stroke 33,808 0.6 1.0 3 0.1 0.4 (0.1–1.3) 1 0.2 0.4 (0.1–3.0) 20 1.7 1.5 (1.0–2.4)
Other diseases of the circulatory system 502,
776
9.3 1.0 158 7.2 1.3 (1.1–1.5) 49 8.0 1.2 (0.9–1.6) 316 27.3 1.7 (1.5–1.9)
IR incidence rate, IRR incidence rate ratio
*Reference group included person-time accumulated from women who did not have any breast diagnostic workup during the follow-up and the person-time
accumulated before the start of workup from women with a breast diagnostic workup during the follow-up
†CI confidence interval. IRRs were estimated using Poisson regression, by using attained age as the underlying timescale and adjusting for cohabitation status,
registered parish as a proxy for socioeconomic status, and preexisting psychiatric disorders (for outcome of psychiatric disorders) or preexisting cardiovascular
diseases (for outcome of cardiovascular diseases)
Table 4 Incidence rates (IRs, per 1000 person-months) and
incidence rate ratios (IRRs) of psychiatric disorders and
cardiovascular diseases during 6 weeks before diagnosis among
women that had a breast diagnostic workup during 2005–2014
in Skåne, Sweden, a within-individual comparison
No. of events Crude IR IRR (95% CI)†
Psychiatric disorder
Reference period* 29,010 17.5 1.0
Unspecified lump in breast 578 26.4 1.0 (0.9–1.1)
Benign tumor 155 25.2 1.3 (1.1–1.5)
Breast cancer 278 24.0 1.4 (1.2–1.6)
Cardiovascular disease
Reference period* 25,675 15.5 1.0
Unspecified lump in breast 297 13.6 0.9 (0.8–1.1)
Benign tumor 116 18.9 1.3 (1.1–1.5)
Breast cancer 777 67.2 1.8 (1.7–2.0)
IR incidence rate, IRR incidence rate ratio
*Reference period included person-time accumulated before the start of
workup from women with a breast diagnostic workup during the follow-up
†CI confidence interval. IRRs were estimated using conditional Poisson
regression, by using attained age as the underlying timescale
Shen et al. Breast Cancer Research          (2019) 21:139 Page 6 of 10
cancer screening programs further underline the poten-
tial lack of generalizability of previous findings. Finally,
the precise size of the population “exposed” to cancer
diagnostic workup is unknown but presumably large,
suggesting that cancer diagnostic workup and its result-
ant health impact do not only apply to cancer patients
but also to a much larger population not destined to de-
veloping cancer.
Studies on cancer diagnostic workup are challenging
because there is usually a lack of detailed data on the en-
tire care process of patients with a suspected cancer. For
example, it is difficult to follow patients over time and
between various healthcare levels. Given the data
sources concerning all health care provided to the entire
female population of Skåne region, we had the unique
opportunity to systematically assess the potential
negative health impact of cancer diagnostic workup. Our
novel results demonstrated increased risks of two con-
crete health outcomes that are known to be associated
with severe psychological distress, namely psychiatric
disorders and cardiovascular diseases, in relation to a
diagnostic workup of potential breast cancer. The in-
creased rates of these two outcomes during the 6 weeks
before the diagnosis of breast cancer and benign breast
tumor but not unspecified lump in breast might be due
to severer symptoms and their resultant psychological
distress among women with a benign tumor or cancer,
compared to women with an unspecified lump. For in-
stance, it has been hypothesized that the tumor-related
inflammation may also contribute to the development of
ill mental-health, including stress-related disorders [28,
29]. The fact that greater rate increase of psychiatric dis-
orders and cardiovascular diseases was noted during a
breast diagnostic workup due to symptoms, compared to
mammography screening, might suggest that findings
generated from previous studies using cancer screening
programs might have underestimated the health impact
of symptom-based clinical evaluations for potential can-
cer [30, 31]. Among all women that underwent a breast
diagnostic workup in the present study, only 30% were
eventually diagnosed with and treated for breast cancer.
Finally, although no overall rate increase was observed
among women with unspecified lump in breast, the
present study did suggest a higher rate of psychiatric dis-
orders in relation to the diagnostic workup of unspeci-
fied lump among women that were at low baseline risk
of the outcome otherwise (i.e., without previous history
of psychiatric disorders). The greater risk increase for
women without a preexisting psychiatric disorder was
also seen for women with benign tumor or breast can-
cer, highlighting again the impact of breast cancer diag-
nostic workup among the women with otherwise low
risk of psychiatric disorders.
To our knowledge, we are the first to contrast the
rates of psychiatric disorders and cardiovascular diseases
during the waiting time for a potential cancer diagnosis
to the corresponding rates during the waiting time for
primary treatment. We focused on surgery, because 90%
of the breast cancer patients received surgical treatment
in the study. The rate increases of psychiatric disorders
and cardiovascular diseases were similar during the
6 weeks before diagnosis compared to the rate increases
during the time from diagnosis to surgery, suggesting a
sustained high level of psychological distress both while
awaiting for a diagnosis and after receiving such diagno-
sis. A limitation of the present study is that we had little
clinical information about the women that underwent a
breast diagnostic workup, except the estimated indica-
tion for workup, i.e., due to symptoms or screening. Fu-
ture studies with more detailed clinical information are
Table 5 Incidence rates (IRs, per 1000 person-months) and
incidence rate ratios (IRRs) of psychiatric disorders and
cardiovascular diseases during the 6 weeks before diagnosis,
among women that had a breast diagnostic workup during
2009–2014 in Skåne, Sweden, analysis according to reason for
diagnostic workup
No. of events Crude IR IRR (95% CI)†
Psychiatric disorder
Reference group* 679,051 20.8 1.0
Due to screening
Unspecified lump in breast 27 27.7 1.2 (0.8–1.8)
Benign tumor 31 23.5 1.2 (0.8–1.7)
Breast cancer 69 20.6 1.0 (0.8–1.3)
Due to symptom
Unspecified lump in breast 413 29.9 1.1 (1.0–1.3)
Benign tumor 78 31.7 1.3 (1.0–1.6)
Breast cancer 139 35.8 1.7 (1.4–2.0)
Cardiovascular disease
Reference group* 740,161 22.7 1.0
Due to screening
Unspecified lump in breast 22 22.6 1.3 (0.9–1.9)
Benign tumor 38 28.8 1.4 (1.1–2.0)
Breast cancer 131 39.1 1.3 (1.1–1.6)
Due to symptom
Unspecified lump in breast 181 13.1 1.0 (0.9–1.1)
Benign tumor 44 17.9 1.2 (0.9–1.6)
Breast cancer 439 113.2 2.3 (2.1–2.5)
IR incidence rate, IRR incidence rate ratio
*Reference group included person-time accumulated from women who did
not have any breast diagnostic workup during the follow-up and the person-
time accumulated before the start of workup from women with a breast
diagnostic workup during the follow-up
†CI confidence interval. IRRs were estimated using Poisson regression, by using
attained age as the underlying timescale and adjusting for cohabitation status,
registered parish as a proxy for socioeconomic status, and preexisting
psychiatric disorders (for outcome of psychiatric disorders) or preexisting
cardiovascular diseases (for outcome of cardiovascular diseases)
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needed to better identify women at high risk of either
psychiatric disorders or cardiovascular diseases during a
breast diagnostic workup. Such additional knowledge,
together with our findings, would better motivate clinical
surveillance and, potentially, intervention of psychiatric
disorders and cardiovascular diseases among high-risk
women, both during the clinical evaluation of a potential
breast cancer and when the patients are awaiting for the
start of primary treatment.
Major strengths of our study include the large-scale
population-based cohort design and the minimized se-
lection and information biases given the prospectively
and independently collected data from different registers
and the complete follow-up. The coverage of the SHR
on all levels of healthcare visits in Skåne made it possible
to capture both severer outcomes that require specialist
care and milder outcomes that require only primary
care. The within-individual comparison, comparing dif-
ferent time periods of the same individual, eliminated
further the potential impact of unknown and unmeas-
ured confounders that are constant within each individ-
ual. Another novelty of the present study, compared to
previous studies including our own [17], is the focus on
the cancer diagnostic workup, especially the 6 weeks be-
fore diagnosis, to assess the role of clinical evaluation for
a potential breast cancer on the risks of psychiatric dis-
orders and cardiovascular disease, and to study not only
women that were eventually diagnosed with breast can-
cer but also women that did not receive a cancer diagno-
sis after the clinical evaluation.
A limitation is the lack of data on other factors that
might either confound or modify the association of can-
cer diagnostic workup with the risk of psychiatric disor-
ders or cardiovascular diseases, including race or
ethnicity, use of psychiatric medications, and family his-
tory of cancer, psychiatric disorders, or cardiovascular
diseases. Further, the use of registered parish as a proxy
for socioeconomic status and the use of cohabitation sta-
tus as a proxy for marital status might have induced re-
sidual confounding to some extent. It also prohibited us
from studying specific groups of vulnerable women, for
instance, divorced or widowed women. Another limita-
tion is the small number of outcomes in some subgroup
analyses, which made the interpretation of these analyses
difficult. Although some women had both psychiatric
disorders and cardiovascular diseases during the 6 weeks
before diagnosis, the proportions are small (0.7% of all
women with lump, 0.09% of all women with benign
tumor, and 0.8% of all women with breast cancer). We
did not validate the diagnoses of the studied psychiatric
disorders and cardiovascular diseases using SHR in the
present study because previous studies have however
shown satisfactory quality of such register-based defini-
tions [32–34]. In addition, because of the increasing
awareness and therefore registration during the study
period in Sweden and Skåne, the definitions of psychi-
atric disorders and cardiovascular diseases included
more milder conditions in later years compared to earl-
ier years. Assuming that the psychological distress expe-
rienced during a breast diagnostic workup is related to
relatively severe forms of these outcomes, such a tem-
poral trend might have contributed to the stronger asso-
ciation noted during the earlier calendar period,
compared to later calendar period. Another possible
contribution to the stronger association during earlier
calendar period is the increasing uptake of breast screen-
ing program during the study period, as we found that
the association was indeed stronger for breast diagnostic
workup due to symptoms, compared to diagnostic
workup due to screening. Furthermore, we could not
identify the precise time when the patient was informed
about cancer diagnosis, if there was a cancer diagnosis,
using either the Cancer Register or SHR. We focused on
the diagnostic workup of breast cancer in the present
study, because patients with breast cancer have been re-
ported to be at the highest prevalence of psychiatric dis-
orders, compared to patients with other cancer types
[35]. The findings of the present study might also be
generalizable to diagnostic workup of other cancer types.
For instance, increased level of psychological distress has
been reported among men undergoing a clinical evalu-
ation for potential prostate cancer, especially when wait-
ing for the result of prostate biopsy [6]. Finally, whether
or not the present findings are generalizable to other
populations remains to be assessed.
Conclusions
In conclusion, using a large population-based cohort
with a follow-up of 10 years, we demonstrated that
women had increased risks of psychiatric disorders and
cardiovascular diseases during diagnostic workup of po-
tential breast cancer. The risk increases were greater
when the diagnostic workup was due to symptoms, com-
pared to when the diagnostic workup was due to screen-
ing. Future research is needed to understand the
underlying reasons for such risk increases.
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